taking medical innovation to market

at Kaerus Consulting we complement your team to ensure your innovations are taken to market faster, with lower risk and higher returns
experiment and microscope

Director

Our Director will work with you bringing years of experience and expertise into your organisation to work with your team.

Dr Jo Proffitt

A knowledgeable and experienced scientist and project manager with over 20 year's experience in the medical device and drug development industry taking products from early phase development through proof of concept to regulatory approval or clinical studies. Proficient in the preparation of expert reports and technical dossiers, with a comprehensive understanding of potential development hurdles and regulatory expectations. Direct experience of regulatory submissions and meetings with regulatory authorities at different stages of the development process. Specialist expertise in wound repair, regenerative medicine, biological derived scaffolds, soft tissue, orthopaedics and cardiovascular repair.

After completing a PhD in Molecular Biology in 1994, Jo started her career in drug development at Covance Laboratories, a global contract research organisation. After working as a Study Director and then Section Head, Biotechnology, Jo moved into the Programme Management function where she was responsible for the leadership and management of programmes of work (both Biologicals and New Chemical Entities, NCEs) on behalf of start-up and virtual companies. This role was multi-faceted, including liaison with regulatory agencies, design and coordination of preclinical studies and provision of strategic, regulatory and technical advice to ensure maximum efficiency for the client.

In 2003 Jo transferred to the Medical Devices industry, taking on the role of Project Manager at Tissue Science Laboratories (TSL), a successful UK based MedTech company. Jo rapidly progressed to role of Associate Director of R&D where she was responsible for the management and direction of the R&D function with a new product pipeline exploiting and maximising the company's core proprietary technology. As well as managing the new product development (NPD) group Jo also played a pivotal role in the technical support and continued development of the core product for both US and EU markets. TSL was sold to Covidien, a multinational healthcare company in 2008 and Jo continued with Covidien as Director of R&D where she held a key role in the integration and translation of the TSL technology into the organisation, from due diligence following acquisition to implementation of external research projects to support Covidien's Regulatory and Sales and Marketing strategies for the TSL development pipeline and launched products.

Jo has been an independent consultant since early 2010 working with start-up, spin-out and small SME MedTech companies, providing expertise and support tailored to the clients' needs from stand-alone expert reviews to full time project management of development projects.


© 2015 Kaerus Consulting Limited, Registered Office - 22 Victoria Avenue, Harrogate, North Yorkshire, HG1 5PR. Company Number 7174792                         Website & Design credits